Cargando…
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study
BACKGROUND: Based on the few available studies on the prognostic benefit of using direct oral anticoagulants (DOACs) after atrial fibrillation (AF) ablation. Therefore, this study aimed to evaluate the prognostic differences between patients who underwent radiofrequency ablation (RFA) and those with...
Autores principales: | Wu, Shuyi, Guan, Chengfu, Xu, Wenlin, Zhang, Feilong, Huang, Nianxu, Chen, Xia, Zhang, Wang, Hu, Wei, Su, Jun, Dai, Hengfen, Gu, Ping, Huang, Xiaohong, Du, Xiaoming, Li, Ruijuan, Zheng, Qiaowei, Lin, Xiangsheng, Zhang, Yanxia, Zou, Lang, Liu, Yuxin, Zhang, Min, Liu, Xiumei, Zhu, Zhu, Sun, Jianjun, Hong, Shanshan, She, Weibin, Zhang, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074713/ https://www.ncbi.nlm.nih.gov/pubmed/37016388 http://dx.doi.org/10.1186/s12959-023-00483-6 |
Ejemplares similares
-
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study
por: Xu, Wenlin, et al.
Publicado: (2023) -
Rheumatic heart disease burden, trends, and inequalities in Asia, 1990–2019
por: Guan, Chengfu, et al.
Publicado: (2023) -
An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
por: Chang, Sijie, et al.
Publicado: (2023) -
Global burden of cardiovascular disease attributable to metabolic risk factors, 1990–2019: an analysis of observational data from a 2019 Global Burden of Disease study
por: Wu, Shuyi, et al.
Publicado: (2023) -
Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
por: Wu, Jia, et al.
Publicado: (2020)